10/7
11:29 am
clov
Rating for CLOV
Medium
Report
Rating for CLOV
10/7
08:10 am
clov
Clover Health Investments, Corp. (NASDAQ: CLOV) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $4.00 price target on the stock.
Medium
Report
Clover Health Investments, Corp. (NASDAQ: CLOV) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $4.00 price target on the stock.